nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP1A2—type 2 diabetes mellitus	0.165	0.602	CbGaD
Pentamidine—CYP3A4—type 2 diabetes mellitus	0.109	0.398	CbGaD
Pentamidine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0286	0.0651	CbGbCtD
Pentamidine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0229	0.052	CbGbCtD
Pentamidine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0207	0.047	CbGbCtD
Pentamidine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0204	0.0464	CbGbCtD
Pentamidine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0191	0.0434	CbGbCtD
Pentamidine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0184	0.0419	CbGbCtD
Pentamidine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0174	0.0395	CbGbCtD
Pentamidine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0174	0.0395	CbGbCtD
Pentamidine—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0163	0.0371	CbGbCtD
Pentamidine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.016	0.0364	CbGbCtD
Pentamidine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0155	0.0352	CbGbCtD
Pentamidine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.015	0.0342	CbGbCtD
Pentamidine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0148	0.0336	CbGbCtD
Pentamidine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0132	0.03	CbGbCtD
Pentamidine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.013	0.0296	CbGbCtD
Pentamidine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0122	0.0277	CbGbCtD
Pentamidine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0116	0.0265	CbGbCtD
Pentamidine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0116	0.0264	CbGbCtD
Pentamidine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.011	0.025	CbGbCtD
Pentamidine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0106	0.0241	CbGbCtD
Pentamidine—CYP3A5—Losartan—type 2 diabetes mellitus	0.0101	0.0229	CbGbCtD
Pentamidine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.01	0.0227	CbGbCtD
Pentamidine—CYP2C8—Losartan—type 2 diabetes mellitus	0.00969	0.022	CbGbCtD
Pentamidine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00959	0.0218	CbGbCtD
Pentamidine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00928	0.0211	CbGbCtD
Pentamidine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00889	0.0202	CbGbCtD
Pentamidine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00839	0.0191	CbGbCtD
Pentamidine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00813	0.0185	CbGbCtD
Pentamidine—CYP1A2—Losartan—type 2 diabetes mellitus	0.0075	0.0171	CbGbCtD
Pentamidine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00636	0.0145	CbGbCtD
Pentamidine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0061	0.0139	CbGbCtD
Pentamidine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0061	0.0139	CbGbCtD
Pentamidine—S100B—peripheral nervous system—type 2 diabetes mellitus	0.00587	0.148	CbGeAlD
Pentamidine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00577	0.0131	CbGbCtD
Pentamidine—S100B—artery—type 2 diabetes mellitus	0.00461	0.116	CbGeAlD
Pentamidine—S100B—nerve—type 2 diabetes mellitus	0.00457	0.115	CbGeAlD
Pentamidine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0043	0.00977	CbGbCtD
Pentamidine—TRDMT1—cardiovascular system—type 2 diabetes mellitus	0.00408	0.103	CbGeAlD
Pentamidine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00393	0.00893	CbGbCtD
Pentamidine—AOC1—nephron tubule—type 2 diabetes mellitus	0.00205	0.0515	CbGeAlD
Pentamidine—S100B—retina—type 2 diabetes mellitus	0.00189	0.0477	CbGeAlD
Pentamidine—AOC1—kidney—type 2 diabetes mellitus	0.0018	0.0452	CbGeAlD
Pentamidine—AOC1—cortex of kidney—type 2 diabetes mellitus	0.00175	0.0441	CbGeAlD
Pentamidine—S100B—cardiovascular system—type 2 diabetes mellitus	0.0016	0.0403	CbGeAlD
Pentamidine—CYP4A11—kidney—type 2 diabetes mellitus	0.00149	0.0376	CbGeAlD
Pentamidine—CYP4A11—cortex of kidney—type 2 diabetes mellitus	0.00145	0.0366	CbGeAlD
Pentamidine—S100B—adipose tissue—type 2 diabetes mellitus	0.00141	0.0356	CbGeAlD
Pentamidine—AOC1—liver—type 2 diabetes mellitus	0.00114	0.0286	CbGeAlD
Pentamidine—CYP4A11—liver—type 2 diabetes mellitus	0.000944	0.0238	CbGeAlD
Pentamidine—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000468	0.0118	CbGeAlD
Pentamidine—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000377	0.00948	CbGeAlD
Pentamidine—CYP2C8—kidney—type 2 diabetes mellitus	0.000367	0.00924	CbGeAlD
Pentamidine—CYP1A1—kidney—type 2 diabetes mellitus	0.000339	0.00852	CbGeAlD
Pentamidine—CYP3A5—kidney—type 2 diabetes mellitus	0.000331	0.00834	CbGeAlD
Pentamidine—CYP3A5—pancreas—type 2 diabetes mellitus	0.000329	0.00828	CbGeAlD
Pentamidine—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000323	0.00812	CbGeAlD
Pentamidine—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000305	0.00768	CbGeAlD
Pentamidine—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000299	0.00751	CbGeAlD
Pentamidine—CYP2C19—liver—type 2 diabetes mellitus	0.000266	0.00669	CbGeAlD
Pentamidine—CYP3A4—kidney—type 2 diabetes mellitus	0.000249	0.00626	CbGeAlD
Pentamidine—CYP2D6—kidney—type 2 diabetes mellitus	0.000245	0.00616	CbGeAlD
Pentamidine—CYP2C8—liver—type 2 diabetes mellitus	0.000232	0.00584	CbGeAlD
Pentamidine—CYP1A2—liver—type 2 diabetes mellitus	0.000217	0.00546	CbGeAlD
Pentamidine—CYP1A1—liver—type 2 diabetes mellitus	0.000214	0.00539	CbGeAlD
Pentamidine—CYP3A5—liver—type 2 diabetes mellitus	0.000209	0.00527	CbGeAlD
Pentamidine—Ospemifene—CYP3A4—type 2 diabetes mellitus	0.000203	1	CrCbGaD
Pentamidine—CYP3A4—liver—type 2 diabetes mellitus	0.000157	0.00395	CbGeAlD
Pentamidine—CYP2D6—liver—type 2 diabetes mellitus	0.000155	0.00389	CbGeAlD
Pentamidine—Tremor—Losartan—type 2 diabetes mellitus	8.43e-05	0.000527	CcSEcCtD
Pentamidine—Rash—Glimepiride—type 2 diabetes mellitus	8.42e-05	0.000526	CcSEcCtD
Pentamidine—Dermatitis—Glimepiride—type 2 diabetes mellitus	8.41e-05	0.000525	CcSEcCtD
Pentamidine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	8.41e-05	0.000525	CcSEcCtD
Pentamidine—Rash—Sitagliptin—type 2 diabetes mellitus	8.39e-05	0.000524	CcSEcCtD
Pentamidine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	8.38e-05	0.000524	CcSEcCtD
Pentamidine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	8.38e-05	0.000524	CcSEcCtD
Pentamidine—Headache—Glimepiride—type 2 diabetes mellitus	8.36e-05	0.000522	CcSEcCtD
Pentamidine—Cough—Irbesartan—type 2 diabetes mellitus	8.35e-05	0.000521	CcSEcCtD
Pentamidine—Headache—Sitagliptin—type 2 diabetes mellitus	8.34e-05	0.000521	CcSEcCtD
Pentamidine—Anaemia—Losartan—type 2 diabetes mellitus	8.32e-05	0.00052	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	8.28e-05	0.000517	CcSEcCtD
Pentamidine—Hypertension—Irbesartan—type 2 diabetes mellitus	8.26e-05	0.000516	CcSEcCtD
Pentamidine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	8.24e-05	0.000515	CcSEcCtD
Pentamidine—Flushing—Ramipril—type 2 diabetes mellitus	8.23e-05	0.000514	CcSEcCtD
Pentamidine—Angioedema—Losartan—type 2 diabetes mellitus	8.23e-05	0.000514	CcSEcCtD
Pentamidine—Infection—Metformin—type 2 diabetes mellitus	8.22e-05	0.000513	CcSEcCtD
Pentamidine—Insomnia—Valsartan—type 2 diabetes mellitus	8.22e-05	0.000513	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	8.18e-05	0.000511	CcSEcCtD
Pentamidine—Paraesthesia—Valsartan—type 2 diabetes mellitus	8.16e-05	0.000509	CcSEcCtD
Pentamidine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	8.15e-05	0.000509	CcSEcCtD
Pentamidine—Arthralgia—Irbesartan—type 2 diabetes mellitus	8.14e-05	0.000509	CcSEcCtD
Pentamidine—Myalgia—Irbesartan—type 2 diabetes mellitus	8.14e-05	0.000509	CcSEcCtD
Pentamidine—Chest pain—Irbesartan—type 2 diabetes mellitus	8.14e-05	0.000509	CcSEcCtD
Pentamidine—Shock—Metformin—type 2 diabetes mellitus	8.14e-05	0.000508	CcSEcCtD
Pentamidine—Insomnia—Orlistat—type 2 diabetes mellitus	8.12e-05	0.000507	CcSEcCtD
Pentamidine—Anxiety—Irbesartan—type 2 diabetes mellitus	8.12e-05	0.000507	CcSEcCtD
Pentamidine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8.11e-05	0.000507	CcSEcCtD
Pentamidine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	8.1e-05	0.000506	CcSEcCtD
Pentamidine—Dyspnoea—Valsartan—type 2 diabetes mellitus	8.1e-05	0.000506	CcSEcCtD
Pentamidine—Vertigo—Losartan—type 2 diabetes mellitus	8.09e-05	0.000505	CcSEcCtD
Pentamidine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	8.09e-05	0.000505	CcSEcCtD
Pentamidine—Somnolence—Valsartan—type 2 diabetes mellitus	8.08e-05	0.000504	CcSEcCtD
Pentamidine—Syncope—Losartan—type 2 diabetes mellitus	8.07e-05	0.000504	CcSEcCtD
Pentamidine—Paraesthesia—Orlistat—type 2 diabetes mellitus	8.06e-05	0.000503	CcSEcCtD
Pentamidine—Leukopenia—Losartan—type 2 diabetes mellitus	8.06e-05	0.000503	CcSEcCtD
Pentamidine—Discomfort—Irbesartan—type 2 diabetes mellitus	8.05e-05	0.000503	CcSEcCtD
Pentamidine—Dyspepsia—Valsartan—type 2 diabetes mellitus	8e-05	0.000499	CcSEcCtD
Pentamidine—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.97e-05	0.000497	CcSEcCtD
Pentamidine—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.96e-05	0.000497	CcSEcCtD
Pentamidine—Palpitations—Losartan—type 2 diabetes mellitus	7.96e-05	0.000497	CcSEcCtD
Pentamidine—Nausea—Glimepiride—type 2 diabetes mellitus	7.93e-05	0.000495	CcSEcCtD
Pentamidine—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.92e-05	0.000495	CcSEcCtD
Pentamidine—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.91e-05	0.000494	CcSEcCtD
Pentamidine—Nausea—Sitagliptin—type 2 diabetes mellitus	7.91e-05	0.000494	CcSEcCtD
Pentamidine—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.9e-05	0.000494	CcSEcCtD
Pentamidine—Asthenia—Glyburide—type 2 diabetes mellitus	7.9e-05	0.000493	CcSEcCtD
Pentamidine—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.9e-05	0.000493	CcSEcCtD
Pentamidine—Anorexia—Metformin—type 2 diabetes mellitus	7.89e-05	0.000493	CcSEcCtD
Pentamidine—Cough—Losartan—type 2 diabetes mellitus	7.86e-05	0.000491	CcSEcCtD
Pentamidine—Urticaria—Gliclazide—type 2 diabetes mellitus	7.86e-05	0.000491	CcSEcCtD
Pentamidine—Fatigue—Valsartan—type 2 diabetes mellitus	7.83e-05	0.000489	CcSEcCtD
Pentamidine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.82e-05	0.000488	CcSEcCtD
Pentamidine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.82e-05	0.000488	CcSEcCtD
Pentamidine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.81e-05	0.000488	CcSEcCtD
Pentamidine—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.8e-05	0.000487	CcSEcCtD
Pentamidine—Pruritus—Glyburide—type 2 diabetes mellitus	7.79e-05	0.000487	CcSEcCtD
Pentamidine—Constipation—Valsartan—type 2 diabetes mellitus	7.77e-05	0.000485	CcSEcCtD
Pentamidine—Infection—Irbesartan—type 2 diabetes mellitus	7.76e-05	0.000484	CcSEcCtD
Pentamidine—Fatigue—Orlistat—type 2 diabetes mellitus	7.74e-05	0.000483	CcSEcCtD
Pentamidine—Hypotension—Metformin—type 2 diabetes mellitus	7.73e-05	0.000483	CcSEcCtD
Pentamidine—Erythema—Ramipril—type 2 diabetes mellitus	7.72e-05	0.000482	CcSEcCtD
Pentamidine—Shock—Irbesartan—type 2 diabetes mellitus	7.68e-05	0.00048	CcSEcCtD
Pentamidine—Pain—Orlistat—type 2 diabetes mellitus	7.68e-05	0.000479	CcSEcCtD
Pentamidine—Chest pain—Losartan—type 2 diabetes mellitus	7.66e-05	0.000479	CcSEcCtD
Pentamidine—Myalgia—Losartan—type 2 diabetes mellitus	7.66e-05	0.000479	CcSEcCtD
Pentamidine—Arthralgia—Losartan—type 2 diabetes mellitus	7.66e-05	0.000479	CcSEcCtD
Pentamidine—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.66e-05	0.000478	CcSEcCtD
Pentamidine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7.64e-05	0.000477	CcSEcCtD
Pentamidine—Anxiety—Losartan—type 2 diabetes mellitus	7.64e-05	0.000477	CcSEcCtD
Pentamidine—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.62e-05	0.000476	CcSEcCtD
Pentamidine—Rash—Bromocriptine—type 2 diabetes mellitus	7.6e-05	0.000474	CcSEcCtD
Pentamidine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.59e-05	0.000474	CcSEcCtD
Pentamidine—Tension—Ramipril—type 2 diabetes mellitus	7.57e-05	0.000473	CcSEcCtD
Pentamidine—Discomfort—Losartan—type 2 diabetes mellitus	7.57e-05	0.000473	CcSEcCtD
Pentamidine—Dysgeusia—Ramipril—type 2 diabetes mellitus	7.56e-05	0.000472	CcSEcCtD
Pentamidine—Headache—Bromocriptine—type 2 diabetes mellitus	7.55e-05	0.000471	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.54e-05	0.000471	CcSEcCtD
Pentamidine—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.53e-05	0.000471	CcSEcCtD
Pentamidine—Nervousness—Ramipril—type 2 diabetes mellitus	7.5e-05	0.000468	CcSEcCtD
Pentamidine—Dry mouth—Losartan—type 2 diabetes mellitus	7.5e-05	0.000468	CcSEcCtD
Pentamidine—Anorexia—Irbesartan—type 2 diabetes mellitus	7.44e-05	0.000465	CcSEcCtD
Pentamidine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.43e-05	0.000464	CcSEcCtD
Pentamidine—Paraesthesia—Metformin—type 2 diabetes mellitus	7.43e-05	0.000464	CcSEcCtD
Pentamidine—Confusional state—Losartan—type 2 diabetes mellitus	7.41e-05	0.000463	CcSEcCtD
Pentamidine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	7.4e-05	0.000462	CcSEcCtD
Pentamidine—Dyspnoea—Metformin—type 2 diabetes mellitus	7.38e-05	0.000461	CcSEcCtD
Pentamidine—Somnolence—Metformin—type 2 diabetes mellitus	7.35e-05	0.000459	CcSEcCtD
Pentamidine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	7.35e-05	0.000459	CcSEcCtD
Pentamidine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7.34e-05	0.000458	CcSEcCtD
Pentamidine—Infection—Losartan—type 2 diabetes mellitus	7.3e-05	0.000456	CcSEcCtD
Pentamidine—Hypotension—Irbesartan—type 2 diabetes mellitus	7.3e-05	0.000456	CcSEcCtD
Pentamidine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.29e-05	0.000455	CcSEcCtD
Pentamidine—Dyspepsia—Metformin—type 2 diabetes mellitus	7.28e-05	0.000455	CcSEcCtD
Pentamidine—Tremor—Ramipril—type 2 diabetes mellitus	7.23e-05	0.000452	CcSEcCtD
Pentamidine—Shock—Losartan—type 2 diabetes mellitus	7.23e-05	0.000451	CcSEcCtD
Pentamidine—Urticaria—Valsartan—type 2 diabetes mellitus	7.22e-05	0.000451	CcSEcCtD
Pentamidine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	7.19e-05	0.000449	CcSEcCtD
Pentamidine—Decreased appetite—Metformin—type 2 diabetes mellitus	7.19e-05	0.000449	CcSEcCtD
Pentamidine—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.18e-05	0.000449	CcSEcCtD
Pentamidine—Tachycardia—Losartan—type 2 diabetes mellitus	7.17e-05	0.000448	CcSEcCtD
Pentamidine—Nausea—Bromocriptine—type 2 diabetes mellitus	7.16e-05	0.000447	CcSEcCtD
Pentamidine—Fatigue—Metformin—type 2 diabetes mellitus	7.13e-05	0.000445	CcSEcCtD
Pentamidine—Urticaria—Orlistat—type 2 diabetes mellitus	7.13e-05	0.000445	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	7.11e-05	0.000444	CcSEcCtD
Pentamidine—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.1e-05	0.000443	CcSEcCtD
Pentamidine—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.1e-05	0.000443	CcSEcCtD
Pentamidine—Asthenia—Gliclazide—type 2 diabetes mellitus	7.09e-05	0.000443	CcSEcCtD
Pentamidine—Constipation—Metformin—type 2 diabetes mellitus	7.07e-05	0.000442	CcSEcCtD
Pentamidine—Angioedema—Ramipril—type 2 diabetes mellitus	7.05e-05	0.000441	CcSEcCtD
Pentamidine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	7.01e-05	0.000438	CcSEcCtD
Pentamidine—Anorexia—Losartan—type 2 diabetes mellitus	7e-05	0.000437	CcSEcCtD
Pentamidine—Vomiting—Glyburide—type 2 diabetes mellitus	7e-05	0.000437	CcSEcCtD
Pentamidine—Pruritus—Gliclazide—type 2 diabetes mellitus	7e-05	0.000437	CcSEcCtD
Pentamidine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.96e-05	0.000435	CcSEcCtD
Pentamidine—Rash—Glyburide—type 2 diabetes mellitus	6.94e-05	0.000434	CcSEcCtD
Pentamidine—Somnolence—Irbesartan—type 2 diabetes mellitus	6.94e-05	0.000433	CcSEcCtD
Pentamidine—Dermatitis—Glyburide—type 2 diabetes mellitus	6.94e-05	0.000433	CcSEcCtD
Pentamidine—Vertigo—Ramipril—type 2 diabetes mellitus	6.94e-05	0.000433	CcSEcCtD
Pentamidine—Syncope—Ramipril—type 2 diabetes mellitus	6.92e-05	0.000432	CcSEcCtD
Pentamidine—Leukopenia—Ramipril—type 2 diabetes mellitus	6.91e-05	0.000432	CcSEcCtD
Pentamidine—Headache—Glyburide—type 2 diabetes mellitus	6.9e-05	0.000431	CcSEcCtD
Pentamidine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.87e-05	0.000429	CcSEcCtD
Pentamidine—Hypotension—Losartan—type 2 diabetes mellitus	6.87e-05	0.000429	CcSEcCtD
Pentamidine—Palpitations—Ramipril—type 2 diabetes mellitus	6.82e-05	0.000426	CcSEcCtD
Pentamidine—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.82e-05	0.000426	CcSEcCtD
Pentamidine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.79e-05	0.000424	CcSEcCtD
Pentamidine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.78e-05	0.000424	CcSEcCtD
Pentamidine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.77e-05	0.000423	CcSEcCtD
Pentamidine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.76e-05	0.000423	CcSEcCtD
Pentamidine—Cough—Ramipril—type 2 diabetes mellitus	6.74e-05	0.000421	CcSEcCtD
Pentamidine—Fatigue—Irbesartan—type 2 diabetes mellitus	6.73e-05	0.00042	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.69e-05	0.000418	CcSEcCtD
Pentamidine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.69e-05	0.000418	CcSEcCtD
Pentamidine—Convulsion—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000418	CcSEcCtD
Pentamidine—Constipation—Irbesartan—type 2 diabetes mellitus	6.68e-05	0.000417	CcSEcCtD
Pentamidine—Pain—Irbesartan—type 2 diabetes mellitus	6.68e-05	0.000417	CcSEcCtD
Pentamidine—Insomnia—Losartan—type 2 diabetes mellitus	6.65e-05	0.000415	CcSEcCtD
Pentamidine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.61e-05	0.000413	CcSEcCtD
Pentamidine—Paraesthesia—Losartan—type 2 diabetes mellitus	6.6e-05	0.000412	CcSEcCtD
Pentamidine—Urticaria—Metformin—type 2 diabetes mellitus	6.57e-05	0.00041	CcSEcCtD
Pentamidine—Myalgia—Ramipril—type 2 diabetes mellitus	6.57e-05	0.00041	CcSEcCtD
Pentamidine—Arthralgia—Ramipril—type 2 diabetes mellitus	6.57e-05	0.00041	CcSEcCtD
Pentamidine—Chest pain—Ramipril—type 2 diabetes mellitus	6.57e-05	0.00041	CcSEcCtD
Pentamidine—Dyspnoea—Losartan—type 2 diabetes mellitus	6.55e-05	0.000409	CcSEcCtD
Pentamidine—Anxiety—Ramipril—type 2 diabetes mellitus	6.55e-05	0.000409	CcSEcCtD
Pentamidine—Nausea—Glyburide—type 2 diabetes mellitus	6.54e-05	0.000409	CcSEcCtD
Pentamidine—Abdominal pain—Metformin—type 2 diabetes mellitus	6.54e-05	0.000408	CcSEcCtD
Pentamidine—Dizziness—Gliclazide—type 2 diabetes mellitus	6.54e-05	0.000408	CcSEcCtD
Pentamidine—Somnolence—Losartan—type 2 diabetes mellitus	6.53e-05	0.000408	CcSEcCtD
Pentamidine—Asthenia—Valsartan—type 2 diabetes mellitus	6.52e-05	0.000407	CcSEcCtD
Pentamidine—Discomfort—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000406	CcSEcCtD
Pentamidine—Dyspepsia—Losartan—type 2 diabetes mellitus	6.47e-05	0.000404	CcSEcCtD
Pentamidine—Asthenia—Orlistat—type 2 diabetes mellitus	6.44e-05	0.000402	CcSEcCtD
Pentamidine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.43e-05	0.000402	CcSEcCtD
Pentamidine—Pruritus—Valsartan—type 2 diabetes mellitus	6.43e-05	0.000401	CcSEcCtD
Pentamidine—Dry mouth—Ramipril—type 2 diabetes mellitus	6.43e-05	0.000401	CcSEcCtD
Pentamidine—Decreased appetite—Losartan—type 2 diabetes mellitus	6.39e-05	0.000399	CcSEcCtD
Pentamidine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.38e-05	0.000399	CcSEcCtD
Pentamidine—Confusional state—Ramipril—type 2 diabetes mellitus	6.35e-05	0.000397	CcSEcCtD
Pentamidine—Pruritus—Orlistat—type 2 diabetes mellitus	6.35e-05	0.000397	CcSEcCtD
Pentamidine—Fatigue—Losartan—type 2 diabetes mellitus	6.33e-05	0.000396	CcSEcCtD
Pentamidine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	6.3e-05	0.000393	CcSEcCtD
Pentamidine—Vomiting—Gliclazide—type 2 diabetes mellitus	6.29e-05	0.000393	CcSEcCtD
Pentamidine—Constipation—Losartan—type 2 diabetes mellitus	6.28e-05	0.000392	CcSEcCtD
Pentamidine—Pain—Losartan—type 2 diabetes mellitus	6.28e-05	0.000392	CcSEcCtD
Pentamidine—Rash—Gliclazide—type 2 diabetes mellitus	6.23e-05	0.000389	CcSEcCtD
Pentamidine—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.23e-05	0.000389	CcSEcCtD
Pentamidine—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.22e-05	0.000388	CcSEcCtD
Pentamidine—Urticaria—Irbesartan—type 2 diabetes mellitus	6.2e-05	0.000387	CcSEcCtD
Pentamidine—Shock—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000387	CcSEcCtD
Pentamidine—Headache—Gliclazide—type 2 diabetes mellitus	6.19e-05	0.000387	CcSEcCtD
Pentamidine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.17e-05	0.000385	CcSEcCtD
Pentamidine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.17e-05	0.000385	CcSEcCtD
Pentamidine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	6.17e-05	0.000385	CcSEcCtD
Pentamidine—Tachycardia—Ramipril—type 2 diabetes mellitus	6.15e-05	0.000384	CcSEcCtD
Pentamidine—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.14e-05	0.000384	CcSEcCtD
Pentamidine—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.05e-05	0.000378	CcSEcCtD
Pentamidine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.01e-05	0.000375	CcSEcCtD
Pentamidine—Dizziness—Valsartan—type 2 diabetes mellitus	6.01e-05	0.000375	CcSEcCtD
Pentamidine—Anorexia—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000375	CcSEcCtD
Pentamidine—Dizziness—Orlistat—type 2 diabetes mellitus	5.94e-05	0.000371	CcSEcCtD
Pentamidine—Asthenia—Metformin—type 2 diabetes mellitus	5.94e-05	0.000371	CcSEcCtD
Pentamidine—Hypotension—Ramipril—type 2 diabetes mellitus	5.89e-05	0.000368	CcSEcCtD
Pentamidine—Nausea—Gliclazide—type 2 diabetes mellitus	5.87e-05	0.000367	CcSEcCtD
Pentamidine—Pruritus—Metformin—type 2 diabetes mellitus	5.85e-05	0.000366	CcSEcCtD
Pentamidine—Urticaria—Losartan—type 2 diabetes mellitus	5.84e-05	0.000365	CcSEcCtD
Pentamidine—Body temperature increased—Losartan—type 2 diabetes mellitus	5.81e-05	0.000363	CcSEcCtD
Pentamidine—Abdominal pain—Losartan—type 2 diabetes mellitus	5.81e-05	0.000363	CcSEcCtD
Pentamidine—Vomiting—Valsartan—type 2 diabetes mellitus	5.78e-05	0.000361	CcSEcCtD
Pentamidine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.75e-05	0.000359	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.74e-05	0.000358	CcSEcCtD
Pentamidine—Rash—Valsartan—type 2 diabetes mellitus	5.73e-05	0.000358	CcSEcCtD
Pentamidine—Dermatitis—Valsartan—type 2 diabetes mellitus	5.72e-05	0.000357	CcSEcCtD
Pentamidine—Vomiting—Orlistat—type 2 diabetes mellitus	5.71e-05	0.000356	CcSEcCtD
Pentamidine—Insomnia—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000356	CcSEcCtD
Pentamidine—Headache—Valsartan—type 2 diabetes mellitus	5.69e-05	0.000355	CcSEcCtD
Pentamidine—Diarrhoea—Metformin—type 2 diabetes mellitus	5.66e-05	0.000354	CcSEcCtD
Pentamidine—Rash—Orlistat—type 2 diabetes mellitus	5.66e-05	0.000353	CcSEcCtD
Pentamidine—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000353	CcSEcCtD
Pentamidine—Dermatitis—Orlistat—type 2 diabetes mellitus	5.65e-05	0.000353	CcSEcCtD
Pentamidine—Headache—Orlistat—type 2 diabetes mellitus	5.62e-05	0.000351	CcSEcCtD
Pentamidine—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.62e-05	0.000351	CcSEcCtD
Pentamidine—Asthenia—Irbesartan—type 2 diabetes mellitus	5.6e-05	0.00035	CcSEcCtD
Pentamidine—Somnolence—Ramipril—type 2 diabetes mellitus	5.6e-05	0.00035	CcSEcCtD
Pentamidine—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.55e-05	0.000346	CcSEcCtD
Pentamidine—Pruritus—Irbesartan—type 2 diabetes mellitus	5.52e-05	0.000345	CcSEcCtD
Pentamidine—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.48e-05	0.000342	CcSEcCtD
Pentamidine—Dizziness—Metformin—type 2 diabetes mellitus	5.47e-05	0.000342	CcSEcCtD
Pentamidine—Fatigue—Ramipril—type 2 diabetes mellitus	5.43e-05	0.000339	CcSEcCtD
Pentamidine—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.41e-05	0.000338	CcSEcCtD
Pentamidine—Nausea—Valsartan—type 2 diabetes mellitus	5.4e-05	0.000337	CcSEcCtD
Pentamidine—Constipation—Ramipril—type 2 diabetes mellitus	5.39e-05	0.000336	CcSEcCtD
Pentamidine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.34e-05	0.000334	CcSEcCtD
Pentamidine—Nausea—Orlistat—type 2 diabetes mellitus	5.33e-05	0.000333	CcSEcCtD
Pentamidine—Asthenia—Losartan—type 2 diabetes mellitus	5.27e-05	0.000329	CcSEcCtD
Pentamidine—Vomiting—Metformin—type 2 diabetes mellitus	5.26e-05	0.000329	CcSEcCtD
Pentamidine—Rash—Metformin—type 2 diabetes mellitus	5.22e-05	0.000326	CcSEcCtD
Pentamidine—Dermatitis—Metformin—type 2 diabetes mellitus	5.21e-05	0.000325	CcSEcCtD
Pentamidine—Pruritus—Losartan—type 2 diabetes mellitus	5.2e-05	0.000325	CcSEcCtD
Pentamidine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.19e-05	0.000324	CcSEcCtD
Pentamidine—Headache—Metformin—type 2 diabetes mellitus	5.18e-05	0.000324	CcSEcCtD
Pentamidine—Dizziness—Irbesartan—type 2 diabetes mellitus	5.16e-05	0.000322	CcSEcCtD
Pentamidine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000322	CcSEcCtD
Pentamidine—Diarrhoea—Losartan—type 2 diabetes mellitus	5.03e-05	0.000314	CcSEcCtD
Pentamidine—Urticaria—Ramipril—type 2 diabetes mellitus	5e-05	0.000313	CcSEcCtD
Pentamidine—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000311	CcSEcCtD
Pentamidine—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000311	CcSEcCtD
Pentamidine—Vomiting—Irbesartan—type 2 diabetes mellitus	4.96e-05	0.00031	CcSEcCtD
Pentamidine—Rash—Irbesartan—type 2 diabetes mellitus	4.92e-05	0.000307	CcSEcCtD
Pentamidine—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.92e-05	0.000307	CcSEcCtD
Pentamidine—Nausea—Metformin—type 2 diabetes mellitus	4.91e-05	0.000307	CcSEcCtD
Pentamidine—Headache—Irbesartan—type 2 diabetes mellitus	4.89e-05	0.000305	CcSEcCtD
Pentamidine—Dizziness—Losartan—type 2 diabetes mellitus	4.86e-05	0.000303	CcSEcCtD
Pentamidine—Vomiting—Losartan—type 2 diabetes mellitus	4.67e-05	0.000292	CcSEcCtD
Pentamidine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.64e-05	0.00029	CcSEcCtD
Pentamidine—Nausea—Irbesartan—type 2 diabetes mellitus	4.64e-05	0.00029	CcSEcCtD
Pentamidine—Rash—Losartan—type 2 diabetes mellitus	4.63e-05	0.000289	CcSEcCtD
Pentamidine—Dermatitis—Losartan—type 2 diabetes mellitus	4.63e-05	0.000289	CcSEcCtD
Pentamidine—Headache—Losartan—type 2 diabetes mellitus	4.6e-05	0.000287	CcSEcCtD
Pentamidine—Asthenia—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000282	CcSEcCtD
Pentamidine—Pruritus—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000278	CcSEcCtD
Pentamidine—Nausea—Losartan—type 2 diabetes mellitus	4.36e-05	0.000273	CcSEcCtD
Pentamidine—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.31e-05	0.000269	CcSEcCtD
Pentamidine—Dizziness—Ramipril—type 2 diabetes mellitus	4.17e-05	0.00026	CcSEcCtD
Pentamidine—Vomiting—Ramipril—type 2 diabetes mellitus	4.01e-05	0.00025	CcSEcCtD
Pentamidine—Rash—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000248	CcSEcCtD
Pentamidine—Dermatitis—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000248	CcSEcCtD
Pentamidine—Headache—Ramipril—type 2 diabetes mellitus	3.95e-05	0.000246	CcSEcCtD
Pentamidine—Nausea—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000234	CcSEcCtD
Pentamidine—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	4.59e-06	5.33e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	4.56e-06	5.3e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	4.55e-06	5.29e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	4.54e-06	5.28e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	4.54e-06	5.28e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	4.52e-06	5.25e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.52e-06	5.25e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	4.5e-06	5.23e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.49e-06	5.21e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	4.45e-06	5.17e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	4.44e-06	5.16e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.36e-06	5.07e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	4.31e-06	5.01e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	4.3e-06	5e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	4.3e-06	5e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	4.3e-06	5e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	4.28e-06	4.97e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GNB3—type 2 diabetes mellitus	4.27e-06	4.96e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.27e-06	4.96e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.26e-06	4.95e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	4.25e-06	4.94e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—HMOX1—type 2 diabetes mellitus	4.25e-06	4.94e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	4.23e-06	4.91e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	4.23e-06	4.91e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	4.22e-06	4.91e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CAT—type 2 diabetes mellitus	4.19e-06	4.87e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	4.19e-06	4.87e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.18e-06	4.86e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	4.17e-06	4.84e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	4.17e-06	4.84e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.12e-06	4.79e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	4.11e-06	4.78e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.1e-06	4.77e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.09e-06	4.76e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	4.09e-06	4.75e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.09e-06	4.75e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—APOB—type 2 diabetes mellitus	4.07e-06	4.73e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.06e-06	4.72e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	4.06e-06	4.72e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	4.06e-06	4.72e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	4.06e-06	4.72e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.05e-06	4.71e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.05e-06	4.71e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	4.04e-06	4.69e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	4.03e-06	4.68e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	4.01e-06	4.67e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	3.96e-06	4.61e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTM1—type 2 diabetes mellitus	3.96e-06	4.6e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.95e-06	4.59e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.95e-06	4.59e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.95e-06	4.59e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.95e-06	4.59e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	3.93e-06	4.57e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	3.92e-06	4.55e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	3.91e-06	4.55e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.91e-06	4.55e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	3.91e-06	4.54e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	3.9e-06	4.53e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	3.89e-06	4.52e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	3.89e-06	4.52e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	3.89e-06	4.52e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	3.86e-06	4.49e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	3.84e-06	4.47e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	3.81e-06	4.42e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.79e-06	4.41e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	3.79e-06	4.41e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.78e-06	4.4e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	3.73e-06	4.34e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.73e-06	4.33e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.73e-06	4.33e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	3.7e-06	4.31e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	3.69e-06	4.29e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.65e-06	4.25e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.65e-06	4.24e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	3.64e-06	4.23e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	3.64e-06	4.23e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	3.64e-06	4.23e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	3.63e-06	4.22e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	3.63e-06	4.22e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	3.58e-06	4.16e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	3.56e-06	4.14e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.54e-06	4.12e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	3.52e-06	4.09e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.52e-06	4.09e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	3.5e-06	4.07e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.49e-06	4.06e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.49e-06	4.06e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.49e-06	4.06e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	3.49e-06	4.05e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.48e-06	4.04e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	3.48e-06	4.04e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.47e-06	4.03e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	3.46e-06	4.02e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	3.45e-06	4.01e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	3.43e-06	3.99e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.43e-06	3.99e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	3.41e-06	3.96e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	3.39e-06	3.94e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	3.34e-06	3.89e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.33e-06	3.87e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.33e-06	3.87e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	3.33e-06	3.87e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.29e-06	3.83e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.28e-06	3.82e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	3.27e-06	3.8e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	3.26e-06	3.79e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.24e-06	3.77e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	3.22e-06	3.74e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.22e-06	3.74e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.22e-06	3.74e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.21e-06	3.73e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.21e-06	3.73e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.21e-06	3.73e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	3.21e-06	3.73e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.2e-06	3.72e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.2e-06	3.72e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.18e-06	3.7e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.16e-06	3.67e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.16e-06	3.67e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.16e-06	3.67e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.15e-06	3.67e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	3.15e-06	3.66e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.13e-06	3.64e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.13e-06	3.64e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.13e-06	3.64e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.12e-06	3.62e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.11e-06	3.62e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.1e-06	3.61e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.06e-06	3.56e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.06e-06	3.56e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	3.05e-06	3.54e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.02e-06	3.51e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.02e-06	3.51e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	3e-06	3.49e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	3e-06	3.48e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.99e-06	3.47e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.98e-06	3.47e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.98e-06	3.46e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2.95e-06	3.43e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	2.95e-06	3.42e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.93e-06	3.4e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.86e-06	3.33e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.86e-06	3.33e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.85e-06	3.32e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	2.84e-06	3.3e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—AKT1—type 2 diabetes mellitus	2.83e-06	3.29e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.81e-06	3.27e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.81e-06	3.27e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.81e-06	3.27e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.81e-06	3.27e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	2.78e-06	3.24e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.78e-06	3.23e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.76e-06	3.21e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.75e-06	3.19e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.73e-06	3.18e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.72e-06	3.16e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.72e-06	3.16e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.72e-06	3.16e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.71e-06	3.15e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	2.7e-06	3.14e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.68e-06	3.11e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.68e-06	3.11e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.67e-06	3.11e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.67e-06	3.1e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.64e-06	3.06e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.63e-06	3.06e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	2.6e-06	3.02e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.6e-06	3.02e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.58e-06	3e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	2.58e-06	3e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	2.58e-06	3e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.57e-06	2.99e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2.55e-06	2.97e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	2.55e-06	2.97e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.54e-06	2.96e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.54e-06	2.96e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.53e-06	2.93e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.5e-06	2.91e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.48e-06	2.88e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.46e-06	2.86e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.45e-06	2.85e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.44e-06	2.84e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	2.44e-06	2.84e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.44e-06	2.83e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.44e-06	2.83e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.43e-06	2.82e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.42e-06	2.82e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.42e-06	2.81e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.36e-06	2.75e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.35e-06	2.74e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.34e-06	2.72e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.33e-06	2.7e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.32e-06	2.7e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.28e-06	2.65e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.24e-06	2.6e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.24e-06	2.6e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.23e-06	2.59e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.23e-06	2.59e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.19e-06	2.54e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.14e-06	2.48e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.12e-06	2.46e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.1e-06	2.44e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.1e-06	2.44e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.1e-06	2.44e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.09e-06	2.43e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.09e-06	2.43e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.08e-06	2.42e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.08e-06	2.41e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.06e-06	2.4e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.05e-06	2.39e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.05e-06	2.38e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2e-06	2.33e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2e-06	2.32e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2e-06	2.32e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.95e-06	2.26e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.92e-06	2.23e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.91e-06	2.22e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.87e-06	2.18e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.87e-06	2.17e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.84e-06	2.14e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.84e-06	2.14e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.83e-06	2.12e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.82e-06	2.11e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.81e-06	2.1e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.79e-06	2.09e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.77e-06	2.06e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.72e-06	2e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.69e-06	1.96e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.68e-06	1.95e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.64e-06	1.9e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.63e-06	1.89e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.61e-06	1.87e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.6e-06	1.86e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.59e-06	1.84e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.56e-06	1.81e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.56e-06	1.81e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.42e-06	1.65e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.4e-06	1.62e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.37e-06	1.59e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.26e-06	1.46e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.2e-06	1.4e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.2e-06	1.4e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.19e-06	1.38e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	1.12e-06	1.3e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.1e-06	1.28e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.03e-06	1.2e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	9.18e-07	1.07e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	8.45e-07	9.82e-06	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	7.15e-07	8.32e-06	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.52e-07	6.42e-06	CbGpPWpGaD
